A Novel Frameshift Mutation of the ALDOB Gene in a Korean Girl Presenting with Recurrent Hepatitis Diagnosed as Hereditary Fructose Intolerance by Choi, Hae-Won et al.
Case report
Gut and Liver, Vol. 6, No. 1, January 2012, pp. 126-128
A Novel Frameshift Mutation of the ALDOB Gene in a Korean Girl Presenting 
with Recurrent Hepatitis Diagnosed as Hereditary Fructose Intolerance 
Hae-Won Choi*, Yeoun Joo Lee*, Seak Hee Oh*, Kyung Mo Kim*, Jeong-Min Ryu*, Beom Hee Lee*
,†, Gu-Hwan Kim
†, 
and Han-Wook Yoo*
,†
*Department of Pediatrics and 
̈Medical Genetics Clinic and Laboratory, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 
Korea
Hereditary fructose intolerance is an autosomal reces-
sive disorder that is caused by a deficiency in fructose-1-
phosphate aldolase (Aldolase B). Children can present with 
hypoglycemia, jaundice, elevated liver enzymes and hepato-
megaly after intake of dietary fructose. Long-term intake of 
fructose in undiagnosed patients can result in hepatic failure 
or renal failure. We experienced a case of hereditary fructose 
intolerance presenting as recurrent hepatitis-like episodes. 
Detailed evaluation of her dietary habits revealed her avoid-
ance of sweetened foods and fruits. Genetic analysis of 
ALDOB revealed that she is a homozygote for a novel frame-
shifting mutation c[758_759insT]+[758_759insT] (p.[val25
3fsX24]+[val253fsX24]). This report is the ﬁ  rst of a Korean 
patient diagnosed with hereditary fructose intolerance using 
only molecular testing without undergoing intravenous fruc-
tose tolerance test or enzyme assay. (Gut Liver 2012;6:126-
128)
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INTRODUCTION
Hereditary fructose intolerance (HFI, OMIM# 229600) is 
an autosomal recessive disorder, caused by a deficiency in 
fructose-1-phosphate aldolase (Aldolase B) which exists in the 
liver, kidney, and intestines.
1 Deficiency of this enzyme causes 
an accumulation of fructose-1-phosphate after fructose intake, 
which results in toxic symptoms like vomiting, hypoglycemia, 
jaundice, elevated liver enzymes and hepatomegaly.
2 HFI was 
diagnosed traditionally by biochemical tests such as intrave-
nous fructose tolerance test or by enzyme assay through liver 
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or small intestine biopsy.
3 Here we report a 2-year-old girl with 
HFI manifesting recurrent hepatitis-like episodes, which was di-
agnosed by the ALDOB gene analysis. 
CASE REPORT
A 2-year-old girl was admitted for the evaluation of recur-
rent episodes of aminotransferase elevation. At 6 month of age, 
she was first diagnosed with hepatitis at another hospital after 
developing fever, vomiting, and diarrhea. She showed hepato-
megaly which was palpable by four finger breadth below the 
costal margin. Laboratory findings revealed elevated aspartate 
aminotransferase (AST) of 2,017 IU/L and alanine aminotrans-
ferase (ALT) of 1,242 IU/L with prothrombin time prolongation. 
No definite cause was found and liver enzymes were normal-
ized after supportive care. She experienced similar episodes of 
aminotransferase elevation at 15-month-old and 23-month-
old of age when she had symptoms of upper respiratory infec-
tions, each revealing AST of 240 IU/L, ALT of 260 IU/L and, 
AST of 457 IU/L, ALT of 530 IU/L. When she was admitted to 
our hospital at 2 years of age, her height was 115.7 cm (25th 
to 50th percentile), and body weight was 12.9 kg (25th to 50th 
percentile). Blood pressure was 116/77 mm Hg, heart rate 136/
min, respiratory rate 32/min, and body temperature was 36
oC 
and there was no abnormal findings on physical examination. 
She had no siblings and no family history of liver disease or 
genetic disease. Blood hemoglobin was 11.8 g/dL, white blood 
cell count 6,200/mm
3 (neutrophils 28%, lymphocytes 54%, 
monocytes 14%, and eosinophils 2%), platelet count 397,000/
mm
3, total protein 7.0 g/dL, albumin 4.0 g/dL, AST 88 IU/L, 
ALT 68 IU/L, total bilirubin 0.4 mg/dL, direct bilirubin 0.1 mg/
dL, gamma-glutamyltranspeptidase 23 IU/L, alkaline phospha-Choi HW, et al: Hereditary Fructose Intolerance Diagnosed by ALDOB Gene Analysis  127
DISCUSSION
Deficiency of fructose-1-phosphate aldolase (aldolase B) 
causes accumulation of fructose-1-phosphate in the liver, kid-
ney, small intestines which leads to symptoms like abdominal 
bloating, vomiting and elevated liver enzymes.
4 Deficiency of 
this enzyme also causes inhibition of other enzymes such as 
fructose-1,6-bisphosphate aldolase and fructokinase, resulting 
in impaired glycogenolysis and gluconeogenesis which can lead 
to fatal hypoglycemia.
5 Chronic ingestion of fructose of sucrose 
results in failure to thrive and repeated episodes of hypogly-
cemia eventually leads to fatal hepatic of renal failure.
2,6-8 Our 
patient presented with typical features of HFI such as vomiting, 
elevated liver enzymes, and hepatomegaly. Other symptoms of 
HFI include lethargy, convulsions, proximal tubular dysfunction 
which our patient didn’t present. However, these manifestations 
can also be found in other metabolic liver diseases including 
galactosemia. For making the diagnosis of HFI, detailed history 
taking, especially for the dietary habit, is important as noted in 
our patient who avoided sweetened foods and fruits. Many pa-
Fig. 1. Microscopic features observed on H&E staining (A) and Masson’s trichome staining (B) of a liver biopsy sample. Moderate macrovesicular 
fatty changes (A, ×200) with periportal and perivenular fibrosis (B, ×40) suggestive of metabolic liver disease. 
Fig. 2. Genomic DNA analysis of 
the ALDOB that the patient car-
ries. A homozygous mutation, 
c.[758_759insT]+[758_759insT](p.[va
l253fsX24]+[val253fsX24]).
tase 187 IU/L, glucose 91 mg/dL, prothrombin time 141% (0.87 
INR), and activated partial thrombin time 27.2 seconds. Sero-
logic markers for hepatitis A virus, hepatitis B virus, hepatitis 
C virus, Epstein-Barr virus, and cytomegalovirus were negative 
and ceruloplasmin, creatine kinase, lactate dehydrogenase were 
normal. Liver sonogram showed hepatomegaly with diffuse 
increased liver parenchymal echogenicity and liver biopsy was 
done. On histologic examination, moderate macrovesicular fatty 
changes with periportal and perivenular fibrosis were noted 
(Fig. 1). With high suspicion of liver disease, we investigated her 
dietary habit, which revealed her self-avoidance of sweetened 
foods and fruits, indicating that she might have HFI. The molec-
ular genetic analysis of the ALDOB gene was performed. Direct 
sequencing of the 8 exons and exon-intron boundaries of AL-
DOB gene on chromosome 9q21.3-22 using DNA isolated from 
peripheral blood showed that the patient is a homozygote for a 
novel frame-shifting mutation c.[758_759insT]+[758_759insT]
(p.[val253fsX24]+[val253fsX24]) (Fig. 2). She is currently on 
fructose-restricted diet with no more episodes of hepatitis. 128  Gut and Liver, Vol. 6, No. 1, January 2012
tients with HFI develop these unpleasant symptoms and hepatic 
dysfunctions after ingesting fructose of sugar. Therefore, treat-
ment of HFI mainly consists of complete elimination of fructose 
and sucrose from the patient’s diet. 
Although diagnosis of HFI was made traditionally by bio-
chemical tests such as intravenous fructose tolerance test or 
by enzyme assay of Aldolase B activity through liver or small 
intestine biopsy, the risks of such procedures can be avoided 
by recent advance in molecular genetic testing.
2 The ALDOB 
gene is located on chromosome 9q22.3.
9,10 More than 50 muta-
tions causing HFI have been reported to date, in which mis-
sense mutations are most common (http://www.hgmd.cf.ac.
uk). p.A149 is the most common genotype identified along with 
p.A174D, p.N334K.
11-13 These three mutations account for 68% 
of HFI alleles worldwide but they are common mostly in north-
ern European populations.
14 The American population shows 
uniquely high prevalence of two nonsense mutations, p.Δ4E4 
and p.R59Op.
15 Spain also shows high prevalence of Δ4E4 sur-
passing p.A174D, p.N334K. New Zealand, India, Japan did not 
have enough published reports to define HFI alleles, indicating 
the existence of variability in the incidence and mutation spec-
trum of HFI among ethnic groups.
15 In Korea, one case of HFI 
has been reported in 2002, which was diagnosed by enzyme 
assay through intestine and liver biopsy, but not by genetic 
testing.
3 Therefore, our patient is the first Korean case with HFI 
confirmed by genetic testing. p.val253fsX24 identified in our 
patient is a novel mutation. This frame-shifting mutation leads 
to premature truncated proteins, and is expected to result in 
functional deterioration of the mutant protein.
The relationship between genotype and symptoms is yet un-
certain.
16 Although earlier studies suggested that patients with 
null alleles presented with more severe phenotypes and higher 
incidence of death,
12,17 current reports show no difference in the 
severity of the symptoms between null alleles and other mis-
sense mutations.
15,18 
In conclusion, to identify more Korean patients with HFI, de-
tailed evaluation of the dietary habit is needed when a patient 
is experiencing recurrent hepatitis-like episodes. The genetic 
testing for ALDOB is a valuable as well accurate method for 
confirming the diagnosis of HFI. 
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